---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-079653"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:03:59.802816+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aptevo raises ~$2.75M gross in registered direct offering at $0.515/share

## Summary
- Offering of 5,339,806 shares (or pre-funded warrants) and 10,679,612 common warrants at $0.515/share; net proceeds ~$2.3M.
- Common warrants exercisable at $0.515/share upon stockholder approval, expire 5 years later.
- Existing warrants from Aug 2023, Nov 2023, Apr 2024 amended to $0.515 exercise price, also subject to stockholder approval.
- Proceeds for clinical development of product candidates and working capital.
- Roth Capital Partners placement agent; closing July 1, 2024.

## SEC filing metadata
- accession: 0000950170-24-079653
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017024079653/0000950170-24-079653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017024079653/apvo-20240628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-079653
- JSON: https://secwatch.observer/filing/0000950170-24-079653.json
- Plain text: https://secwatch.observer/filing/0000950170-24-079653.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.